Mastek is currently trading at Rs. 1717.90, up by 31.35 points or 1.86% from its previous closing of Rs. 1686.55 on the BSE.
The scrip opened at Rs. 1710.00 and has touched a high and low of Rs. 1719.85 and Rs. 1702.45 respectively.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3410.85 on 04-Apr-2022 and a 52 week low of Rs. 1492.00 on 18-Nov-2022.
Last one week high and low of the scrip stood at Rs. 1740.00 and Rs. 1681.00 respectively. The current market cap of the company is Rs. 5073.84 crore.
The promoters holding in the company stood at 37.28%, while Institutions and Non-Institutions held 16.77% and 45.95% respectively.
Mastek has partnered with King Faisal Specialist Hospital & Research Centre (KFSH&RC) to modernize its healthcare services. Through this partnership, Mastek will mark itself as the first implementation partner of its kind in the Kingdom of Saudi Arabia (KSA) region.
Mastek was chosen for this transformative exercise due to its deep expertise in the healthcare vertical, coupled with its digital engineering and cloud capabilities, a vast partner network, and long-term relationship with the client. Further, as a preferred Oracle partner with a strong pool of 2000+ Oracle experts and 100+ industry-specific solutions, Mastek was seen as the right partner to deliver the right outcomes for KFSH&RC.
Mastek implemented Oracle Hyperion Profitability and Cost Management that will help the client to standardize costing methodology, streamline decision making for better healthcare services planning and provide uniform reporting across all the facilities.
Mastek together with its subsidiaries, provides enterprise technology solutions and platforms for insurance, government, and financial services organizations worldwide.
| Company Name | CMP |
|---|---|
| TCS | 2524.35 |
| Infosys | 1292.35 |
| HCL Tech. | 1450.90 |
| Wipro | 204.85 |
| Tech Mahindra | 1440.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: